- Home
- ENX vs BDSX Comparison
ENX vs BDSX Comparison
Compare ENX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- BDSX
- Stock Information
- Founded
- ENX 2002
- BDSX 2005
- Country
- ENX United States
- BDSX United States
- Employees
- ENX N/A
- BDSX N/A
- Industry
- ENX Finance/Investors Services
- BDSX Precision Instruments
- Sector
- ENX Finance
- BDSX Health Care
- Exchange
- ENX Nasdaq
- BDSX Nasdaq
- Market Cap
- ENX 170.1M
- BDSX 200.0M
- IPO Year
- ENX N/A
- BDSX 2020
- Fundamental
- Price
- ENX $9.60
- BDSX $1.38
- Analyst Decision
- ENX
- BDSX Strong Buy
- Analyst Count
- ENX 0
- BDSX 4
- Target Price
- ENX N/A
- BDSX $3.08
- AVG Volume (30 Days)
- ENX 25.4K
- BDSX 353.2K
- Earning Date
- ENX 01-01-0001
- BDSX 11-01-2024
- Dividend Yield
- ENX 3.94%
- BDSX N/A
- EPS Growth
- ENX N/A
- BDSX N/A
- EPS
- ENX 0.16
- BDSX N/A
- Revenue
- ENX N/A
- BDSX $65,562,000.00
- Revenue This Year
- ENX N/A
- BDSX $46.97
- Revenue Next Year
- ENX N/A
- BDSX $30.43
- P/E Ratio
- ENX $61.00
- BDSX N/A
- Revenue Growth
- ENX N/A
- BDSX 48.92
- 52 Week Low
- ENX $7.84
- BDSX $1.15
- 52 Week High
- ENX $10.07
- BDSX $2.21
- Technical
- Relative Strength Index (RSI)
- ENX 47.59
- BDSX 38.82
- Support Level
- ENX $9.52
- BDSX $1.38
- Resistance Level
- ENX $9.71
- BDSX $1.45
- Average True Range (ATR)
- ENX 0.11
- BDSX 0.10
- MACD
- ENX 0.02
- BDSX -0.00
- Stochastic Oscillator
- ENX 62.07
- BDSX 25.00
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.